These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28625829)

  • 1. Combinatorial immunotherapy and nanoparticle mediated hyperthermia.
    Moy AJ; Tunnell JW
    Adv Drug Deliv Rev; 2017 May; 114():175-183. PubMed ID: 28625829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors.
    Cheng Y; Weng S; Yu L; Zhu N; Yang M; Yuan Y
    Integr Cancer Ther; 2019; 18():1534735419876345. PubMed ID: 31522574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Progress in the Synergistic Combination of Nanoparticle-Mediated Hyperthermia and Immunotherapy for Treatment of Cancer.
    Stephen ZR; Zhang M
    Adv Healthc Mater; 2021 Jan; 10(2):e2001415. PubMed ID: 33236511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial Cancer Immunotherapies.
    Hellmann MD; Friedman CF; Wolchok JD
    Adv Immunol; 2016; 130():251-77. PubMed ID: 26923003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment.
    Hou X; Tao Y; Pang Y; Li X; Jiang G; Liu Y
    Int J Cancer; 2018 Dec; 143(12):3050-3060. PubMed ID: 29981170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electro- hyperthermia.
    Kuo IM; Lee JJ; Wang YS; Chiang HC; Huang CC; Hsieh PJ; Han W; Ke CH; Liao ATC; Lin CS
    BMC Cancer; 2020 Jun; 20(1):603. PubMed ID: 32600429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy.
    Lee S; Son B; Park G; Kim H; Kang H; Jeon J; Youn H; Youn B
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune checkpoint inhibitor therapy in advanced head and neck cancer].
    Hang W; Xu ZX; Zhang Q; Lu X; Liu G
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 52(1):67-70. PubMed ID: 28104022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic Overview of Current Immunotherapy Approaches in Cancer.
    Velcheti V; Schalper K
    Am Soc Clin Oncol Educ Book; 2016; 35():298-308. PubMed ID: 27249709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing Hyperthermia: Molecular, Cellular, and Immunological Insights for Enhanced Anticancer Therapies.
    Lukácsi S; Munkácsy G; Győrffy B
    Integr Cancer Ther; 2024; 23():15347354241242094. PubMed ID: 38818970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local tumour hyperthermia as immunotherapy for metastatic cancer.
    Toraya-Brown S; Fiering S
    Int J Hyperthermia; 2014 Dec; 30(8):531-9. PubMed ID: 25430985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Hyperthermia Therapy-Based Synergistic Immunotherapy.
    Chang M; Hou Z; Wang M; Li C; Lin J
    Adv Mater; 2021 Jan; 33(4):e2004788. PubMed ID: 33289219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
    Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
    Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tackling Resistance to Cancer Immunotherapy: What Do We Know?
    Gondhowiardjo SA; Handoko ; Jayalie VF; Apriantoni R; Barata AR; Senoaji F; Utami IJW; Maubere F; Nuryadi E; Giselvania A
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined strategies for tumor immunotherapy with nanoparticles.
    Savitsky K; Yu X
    Clin Transl Oncol; 2019 Nov; 21(11):1441-1449. PubMed ID: 31055713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia.
    Zhang Y; Li Z; Huang Y; Zou B; Xu Y
    Front Immunol; 2023; 14():1258786. PubMed ID: 37869003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect?
    Gerber HP; Sapra P; Loganzo F; May C
    Biochem Pharmacol; 2016 Feb; 102():1-6. PubMed ID: 26686577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.
    Duan X; Chan C; Lin W
    Angew Chem Int Ed Engl; 2019 Jan; 58(3):670-680. PubMed ID: 30016571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and vascular effects of hyperthermia.
    Int J Hyperthermia; 2008 Feb; 24(1):1-2. PubMed ID: 18214764
    [No Abstract]   [Full Text] [Related]  

  • 20. In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence.
    Han X; Wang R; Xu J; Chen Q; Liang C; Chen J; Zhao J; Chu J; Fan Q; Archibong E; Jiang L; Wang C; Liu Z
    Biomaterials; 2019 Dec; 224():119490. PubMed ID: 31542515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.